Clinical Trials Browser

Phase 2 × Dexamethasone × Head & Neck × Clear all

NCT03107182 2025-05-06

OPTIMA-II

Phase 2 Completed

72 enrolled 14 charts

Squamous Cell Carcinoma of Head and Neck

NCT03572829 2020-07-15

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Phase 2 Completed

Head and Neck Neoplasms, Vomiting

NCT02410382 2019-05-14

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

Phase 2 Terminated

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasms

NCT02047253 2018-12-19

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Phase 2 Completed

28 enrolled 12 charts

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

NCT00953420 2017-08-18

CADEN

Phase 2 Completed

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Phase 2 Terminated

6 enrolled 5 charts

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

NCT02061631 2015-10-08

DECIDE

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck